How C. elegans cells take in double-stranded RNA and cholesterol
Import of double-stranded RNA and cholesterol into cells in C. elegans
This study is looking at how tiny worms called C. elegans move important molecules like double-stranded RNA and cholesterol into their cells, which could help us find better ways to deliver treatments for heart-related issues and conditions linked to cholesterol.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Maryland, College Park NIH-funded |
| Lab location | 1 site (College Park, United States) |
| Project ID | NIH-10996829 on NIH RePORTER |
What this research studies
This research investigates how the nematode C. elegans transports double-stranded RNA (dsRNA) and cholesterol into its cells, which is crucial for gene silencing and maintaining cholesterol balance. The study focuses on a specific protein, SID-1, that facilitates the movement of dsRNA between cells and explores its interaction with a newly identified cholesterol transporter. By understanding these mechanisms, the research aims to improve the delivery of RNA-based therapies for cardiovascular diseases. The findings could lead to advancements in how we treat conditions related to cholesterol metabolism and gene expression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cardiovascular diseases or conditions related to cholesterol metabolism.
Not a fit: Patients with non-cardiovascular conditions or those not affected by cholesterol metabolism issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the effectiveness of RNA-based therapies for cardiovascular diseases by improving how these therapies are delivered into cells.
How similar studies have performed: Other research has shown promise in using RNA interference for gene silencing, but the specific mechanisms of dsRNA transport in C. elegans are less explored, making this a novel investigation.
Where this research is happening
College Park, United States
- Univ of Maryland, College Park — College Park, United States (Active)
Researchers
- Principal investigator: Lowers, Victoria — Univ of Maryland, College Park
- Study coordinator: Lowers, Victoria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.